Pfizer Ponders Viagra Lessons to Chart First Obesity Drug Launch

Pfizer Inc. is drawing on lessons learned years ago from rolling out Viagra as it maps out the launch of its first obesity medicine.

The parallels between weight loss and erectile dysfunction — two sensitive health topics influenced by social perceptions — are among the factors helping to inform the US drugmaker as it considers how best to introduce the monthly injection just gained from its acquisition of Metsera Inc., according to Alexandre de Germay, Pfizer’s chief international commercial officer.